Dopamine and the use of SSRIs for condit
β
A. S. Hale
π
Article
π
1996
π
John Wiley and Sons
π
English
β 585 KB
Serotonin reuptake inhibitors (SSRIs) have been used as adjunctive agents in open and recently double blind studies of the treatment of patients with schizophrenia, showing improvements in negative symptoms over 6 months. Extrapyramidal symptoms (EPS) were not exacerbated. Serotonergic blockade is o